Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H25NO2 |
Molecular Weight | 311.418 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@@](O)(CC#N)[C@@]1(C)CCC3=C4CCC(=O)C=C4CC[C@@]23[H]
InChI
InChIKey=AZFLJNIPTRTECV-FUMNGEBKSA-N
InChI=1S/C20H25NO2/c1-19-8-6-16-15-5-3-14(22)12-13(15)2-4-17(16)18(19)7-9-20(19,23)10-11-21/h12,17-18,23H,2-10H2,1H3/t17-,18+,19+,20-/m1/s1
Molecular Formula | C20H25NO2 |
Molecular Weight | 311.418 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:01:30 UTC 2023
by
admin
on
Sat Dec 16 16:01:30 UTC 2023
|
Record UNII |
46M3EV8HHE
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QG03FA15
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-ATC |
G03FA15
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
NDF-RT |
N0000175602
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-VATC |
QG03AB08
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-VATC |
QG03DB08
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-ATC |
G03AB08
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-VATC |
QG03AA16
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
NCI_THESAURUS |
C776
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-ATC |
G03AA16
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
WHO-ATC |
G03DB08
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
||
|
LIVERTOX |
302
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DIENOGEST
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
SUB07108MIG
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
68861
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
Dienogest
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
C023635
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
7654
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
5286
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
22968
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | RxNorm | ||
|
C87238
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
DTXSID80891478
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
100000092815
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
LL-95
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
46M3EV8HHE
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
70708
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
DB08866
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
46M3EV8HHE
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
m4387
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | Merck Index | ||
|
871
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
65928-58-7
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201864
Created by
admin on Sat Dec 16 16:01:31 UTC 2023 , Edited by admin on Sat Dec 16 16:01:31 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> AGONIST | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
Tmax | PHARMACOKINETIC |
|
SINGLE DOSE |
|
||
Volume of Distribution | PHARMACOKINETIC |
|
IV administration |
|
||